TrialBMC cancer2019

Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study.

Ying Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.